Skip to main content

AGMB · Agomab Therapeutics NV · Debt

Track AGMB — free
$13.06 -0.88 (-6.31%) At close · Sep 11
Market Cap
$655.49M
Shares
49.25M

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.

Key facts CIK 2020932 CUSIP 00860C102 13F (30d) 24 filings 24 filers Visit website Investor relations